1. Germline TP53 mutations is common in patients with two early‐onset primary malignancies. (8th October 2014) Authors: Chak, B. P.; Chan, E. S.; Tong, J. H.; Leung, A. W.; Cheng, F. W.; Lam, G. K.; Shing, M. M.; Li, C. K.; To, K. F. Journal: Clinical genetics Issue: Volume 87:Number 5(2015:May) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗